Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4

US5767065A · kind A · utility

Assignee

• IMMUNEX CORPORATION · US

Inventors

• Bruce Mosley · Seattle, US
• David J. Cosman · Bainbridge Island, US
• Linda S. Park · Seattle, US
• M. Patricia Beckmann · Poulsbo, US
• Carl J. March · Bainbridge Island, US
• Rejean Idzerda · Seattle, US

Key dates

• Filing date: Jun 6, 1995
• Grant date: Jun 16, 1998
• Expiry date: Jun 6, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Mammalian Interleukin-4 receptor proteins find use in inhibiting biological activities of IL-4. A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal, including a human, by administering an effective amount of soluble IL-4 receptor (sIL-4R) and a suitable diluent or carrier.